Credence MedSystems’ is developing its Companion family of syringes, which includes proprietary needle-retraction technology in Staked-Needle and Luer formats, and its portfolio has expanded to include Dual Chamber configurations, metered-dose applications and other devices.
Credence MedSystems is focused on the development of its Companion family of syringe systems, which includes proprietary needle-retraction technology, syringe re-use prevention and other critical safety and usability features in staked-needle and Luer formats. Its Dual Chamber Reconstitution platform offers single step mixing and injection for drugs that require reconstitution at the time of delivery. Additional products such as metered dose devices, multi-length staked needles and other novel devices address the needs of specific therapeutic markets.
Credence’s philosophy of Innovation Without Change allows its customers to offer novel, safer delivery devices to their end users while preserving their existing processes, sourcing strategies and preferred primary package components. Credence calls this Innovation Without Change because it offers the innovation of the final device without the change that customarily accompanies combination product development.
Credence MedSystems is a private company.